Legend Biotech Corp. (LEGN)
21.52
-0.23
(-1.06%)
USD |
NASDAQ |
Sep 04, 16:00
21.52
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Research and Development Expense (Quarterly) : 96.16M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.16M |
| March 31, 2026 | 85.96M |
| December 31, 2025 | 101.77M |
| September 30, 2025 | 113.30M |
| June 30, 2025 | 98.65M |
| March 31, 2025 | 101.92M |
| December 31, 2024 | 104.06M |
| September 30, 2024 | 95.52M |
| June 30, 2024 | 112.63M |
| March 31, 2024 | 100.96M |
| December 31, 2023 | 105.68M |
| September 30, 2023 | 95.86M |
| June 30, 2023 | 95.79M |
| March 31, 2023 | 84.89M |
| Date | Value |
|---|---|
| December 31, 2022 | 80.76M |
| September 30, 2022 | 104.52M |
| June 30, 2022 | 68.83M |
| March 31, 2022 | 81.55M |
| December 31, 2021 | 86.50M |
| September 30, 2021 | 72.31M |
| June 30, 2021 | 83.46M |
| March 31, 2021 | 70.93M |
| December 31, 2020 | 67.14M |
| September 30, 2020 | 63.66M |
| June 30, 2020 | 53.57M |
| March 31, 2020 | 48.00M |
| December 31, 2019 | 66.10M |
| September 30, 2019 | 41.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Dianthus Therapeutics, Inc. | 48.69M |
| Gilead Sciences, Inc. | 1.69B |
| Ironwood Pharmaceuticals, Inc. | 21.96M |
| Arbutus Biopharma Corp. | 2.898M |
| Fortress Biotech, Inc. | 0.805M |